Annual Congress Stockholm 2002

Citations should be made in the following way: Authors. Title. Eur Respir J 2002; 20: Suppl. 38, abstract number.

Material from 2002:

Material from 2002: Show

Oral Presentation
Chairs: P. L. Haslam (London, United Kingdom), B. Lachmann (Rotterdam, The Netherlands)

Ultrastructure of the pulmonary surfactant and its alterations after general inhibition of protein synthesis in the rat M. Walski, R. Celary-Walska (Warsaw, Poland)
Evidence of muscle wasting in SP-C/TNFα mice R. C. J. Langen, A. M. W. J. Schols, M. C. J. M. Kelders, J. L. J. van der Velden, E. F. M. Wouters, Y. M. W. Janssen-Heininger (Maastricht, The Netherlands; Burlington, United States Of America)
Translocation of TNF-α from the gut to the lung by VILI is reduced by exogenous surfactant therapy J. J. Haitsma, S. Uhlig, D. L. Poelma, B. Lachmann (Rotterdam, The Netherlands; Borstel, Germany)
Surfactant protein A (SP-A) and alveolar complement activation in patients at-risk for ARDS K. Raymondos, B. Vangerow, B. Hillmer, W. Bernhard, J. Braun, T. Postle, S. Piepenbrock (Hannover, Lübeck, Germany; Southampton, United Kingdom)
Surfactant therapy for ALI. Dose-effect relationship O. A. Rosenberg, A. E. Bautin, V. V. Osovskich, A. A. Seiliev, V. A. Volchkov, D. A. Granov (St-Peterburg, Russia)
Influence of ambroxol for the phospholipid composition of surfactant in pulmonary sarcoidosis H. L. Baradzina, I. L. Kotovich, A. D. Taganovich, G. N. Tamashakina (Minsk, Belarus)
Surfactant pool size is not decreased in neonates with congenital diaphragmatic hernia (CDH) who require ECMO D. J. Janssen, D. Tibboel, V. P. Carnielli, I. H. Luijendijk, D. J. Wattimena, L. J. Zimmermann (Rotterdam, The Netherlands; Padua, Italy)